close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BridgeBio Pharma, Inc. - Common Stock (NQ:BBIO)

75.25 -0.81 (-1.06%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about BridgeBio Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Why Is BridgeBio Pharma Stock Trading Higher On Friday? ↗
BridgeBio Pharma presented additional data from its Phase 3 ATTRibute-CM study of acoramidis in ATTR-CM at the European Society of Cardiology 2024, showing increased serum TTR levels in participants... 
Via Benzinga
News headline image
Marvell Technology Posts Upbeat Sales, Joins MongoDB, Intel, MINISO Group And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Alnylam Pharmaceuticals Stock Falls After Detailed Vutrisiran Data For A Condition With Stiff Heart Muscles ↗
Alnylam Pharmaceuticals shares drop as detailed results from the HELIOS-B Phase 3 study of vutrisiran for ATTR-CM reveal mixed outcomes. Reductions in mortality and cardiovascular events were presented... 
Via Benzinga
News headline image
BBIO Stock Earnings: BridgeBio Pharma Misses EPS, Misses Revenue for Q2 2024 ↗
BBIO stock results show that BridgeBio Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Why BridgeBio Pharma Stock Is Trading Lower Tuesday ↗
BridgeBio Pharma, Inc. 
Via Benzinga
News headline image
Recap: BridgeBio Pharma Q4 Earnings ↗
 
Via Benzinga
News headline image
2 Biotechs That Could Get Bought Out in 2024 ↗
These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason. 
Via The Motley Fool
News headline image
The Latest Analyst Ratings for BridgeBio Pharma ↗
 
Via Benzinga
News headline image
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday ↗
 
Via Benzinga
News headline image
Masters In Trading - Saturday, June 22 ↗
In this video, I discuss a stock that is expected to see major upside, and I take a closer look at my portfolio. 
Via Talk Markets
News headline image
The 3 Best Biotech Stocks to Buy in June 2024 ↗
Explore the best biotech stocks to buy in June 2024, with insights on Protagonist, BridgeBio and Intellia. 
Via InvestorPlace
News headline image
BridgeBio Pharma Shares One Year Data From Dwarfism Candidate ↗
BridgeBio Pharma revealed results from the PROPEL 2 Phase 2 trial of infigratinib in children with achondroplasia. Key data shows sustained increases in height velocity and improved body... 
Via Benzinga
News headline image
BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results ↗
BridgeBio stock rallies on upbeat study results of a drug for a genetic disease that affects the limbs and spine. 
Via Investor's Business Daily
News headline image
7 Biotech Stocks to Put on Your Breakthrough Radar ↗
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance. 
Via InvestorPlace
News headline image
BBIO Stock Earnings: BridgeBio Pharma Beats EPS, Beats Revenue for Q1 2024 ↗
BBIO stock results show that BridgeBio Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
What's Going On With BridgeBio Pharma Stock On Monday? ↗
BridgeBio Pharma partners with Bayer on acoramidis for ATTR-CM in Europe. $310 million deal, FDA application accepted. 
Via Benzinga
News headline image
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out? ↗
BridgeBio will receive a tiered royalty on sales that begins at the low-30% range. 
Via Investor's Business Daily
News headline image
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday. 
Via Benzinga
Topics Stocks
News headline image
3 Groundbreaking Biotech Stocks to Invest in Now ↗
These are several biotech companies for investors seeking unique opportunities for great returns within the industry. 
Via InvestorPlace
News headline image
7 Exciting Stocks Poised for Explosive Growth in Key Sectors ↗
These stocks to buy for growth already have a strong growth story. If they reach their potential investors could see some dynamic returns. 
Via InvestorPlace
News headline image
3 Russell 2000 Stocks That Are About to Get Absolutely Crushed ↗
The Russell 2000 has only begun closing its wide gap with other indices, but investors should be weary of these three stocks to sell. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Why Is Biomarin & BridgeBio Pharma Rival Lumos Pharma Stock Trading Higher Today? ↗
Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2 OraGrowtH212 Pharmacokinetic/Pharmacodynamic (PK/PD) trial met all... 
Via Benzinga
News headline image
Rare Disease Player BridgeBio Pharma's Upside Potential Is Significant According to Citi Analyst - Here's Why ↗
Citi initiated coverage on BridgeBio Pharma Inc (NASDAQ: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, noting an optimistic outlook on the stock. 
Via Benzinga
News headline image
Why BridgeBio Pharma Was a Healthy Stock Today ↗
One of the best-performing biotechs on the stock market this year gets a bullish nod from a researcher. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023 ↗
 
Via Benzinga
News headline image
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty ↗
Raymond James initiated coverage on BioMarin Pharmaceuticals Inc (NASDAQ: BMRN) with a Market Perform rating, noting sparsity in  
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates ↗
These three pharma stocks could be driven higher amidst future revenue prospects as they report to investors positive clinical developments. 
Via InvestorPlace
News headline image
What's Going On With BridgeBio Pharma Stock Today? ↗
BridgeBio Pharma Inc (NASDAQ: BBIO) announced the presentation of detailed results from its Phase 3 ATTRibute-CM study of acoramidis for ATTR-CM at the  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today